These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

175 related items for PubMed ID: 34056691

  • 1. Efonidipine Exerts Cerebroprotective Effect by Down-regulation of TGF-β/SMAD-2-Dependent Signaling Pathway in Diabetic Rats.
    Rajput R, Chavda V, Patel SS, Barreto GE, Ashraf GM.
    J Mol Neurosci; 2021 Sep; 71(9):1884-1896. PubMed ID: 34056691
    [Abstract] [Full Text] [Related]

  • 2. Effect of efonidipine on TGF-β1-induced cardiac fibrosis through Smad2-dependent pathway in rat cardiac fibroblasts.
    Lei B, Hitomi H, Mori T, Nagai Y, Deguchi K, Mori H, Masaki T, Nakano D, Kobori H, Kitaura Y, Nishiyama A.
    J Pharmacol Sci; 2011 Sep; 117(2):98-105. PubMed ID: 21897055
    [Abstract] [Full Text] [Related]

  • 3. Protective effects of efonidipine, a T- and L-type calcium channel blocker, on renal function and arterial stiffness in type 2 diabetic patients with hypertension and nephropathy.
    Sasaki H, Saiki A, Endo K, Ban N, Yamaguchi T, Kawana H, Nagayama D, Ohhira M, Oyama T, Miyashita Y, Shirai K.
    J Atheroscler Thromb; 2009 Oct; 16(5):568-75. PubMed ID: 19749494
    [Abstract] [Full Text] [Related]

  • 4. Combination therapy with irbesartan and efonidipine for attenuation of proteinuria in Dahl salt-sensitive rats.
    Takai S, Jin D, Sakonjo H, Miyazaki M.
    Hypertens Res; 2010 Sep; 33(9):953-9. PubMed ID: 20520612
    [Abstract] [Full Text] [Related]

  • 5. [Effect of efonidipine hydrochloride, a calcium channel blocker, on the experimental cerebral ischemia/anoxia].
    Matsumura T, Furuichi H, Izumi J, Suda H, Ito S, Takei M, Nishi N, Mori T, Tanaka Y, Kurimoto T.
    Nihon Yakurigaku Zasshi; 1995 Jun; 105(6):437-46. PubMed ID: 7557732
    [Abstract] [Full Text] [Related]

  • 6. Promising Anti-stroke Signature of Voglibose: Investigation through In- Silico Molecular Docking and Virtual Screening in In-Vivo Animal Studies.
    Shah P, Chavda V, Patel S, Bhadada S, Ashraf GM.
    Curr Gene Ther; 2020 Jun; 20(3):223-235. PubMed ID: 33054705
    [Abstract] [Full Text] [Related]

  • 7. Neuroprotective effect of lercanidipine in middle cerebral artery occlusion model of stroke in rats.
    Gupta S, Sharma U, Jagannathan NR, Gupta YK.
    Exp Neurol; 2017 Feb; 288():25-37. PubMed ID: 27794423
    [Abstract] [Full Text] [Related]

  • 8. A selective T-type Ca2+ channel blocker R(-) efonidipine.
    Shin MC, Kim CJ, Min BI, Ogawa S, Tanaka E, Akaike N.
    Naunyn Schmiedebergs Arch Pharmacol; 2008 Jun; 377(4-6):411-21. PubMed ID: 18278483
    [Abstract] [Full Text] [Related]

  • 9. Efonidipine reduces proteinuria and plasma aldosterone in patients with chronic glomerulonephritis.
    Ishimitsu T, Kameda T, Akashiba A, Takahashi T, Ohta S, Yoshii M, Minami J, Ono H, Numabe A, Matsuoka H.
    Hypertens Res; 2007 Jul; 30(7):621-6. PubMed ID: 17785930
    [Abstract] [Full Text] [Related]

  • 10. Effects of iron overload, an iron chelator and a T-Type calcium channel blocker on cardiac mitochondrial biogenesis and mitochondrial dynamics in thalassemic mice.
    Khamseekaew J, Kumfu S, Wongjaikam S, Kerdphoo S, Jaiwongkam T, Srichairatanakool S, Fucharoen S, Chattipakorn SC, Chattipakorn N.
    Eur J Pharmacol; 2017 Mar 15; 799():118-127. PubMed ID: 28192097
    [Abstract] [Full Text] [Related]

  • 11. Renal effects of efonidipine hydrochloride, a new calcium antagonist, in spontaneously hypertensive rats with glomerular injury.
    Kawabata M, Ogawa T, Han WH, Takabatake T.
    Clin Exp Pharmacol Physiol; 1999 Sep 15; 26(9):674-9. PubMed ID: 10499155
    [Abstract] [Full Text] [Related]

  • 12. The Ca(2+) channel inhibitor efonidipine decreases voltage-dependent K(+) channel activity in rabbit coronary arterial smooth muscle cells.
    Park MH, Son YK, Hong DH, Choi IW, Kim DJ, Lee H, Bang H, Na SH, Li H, Jo SH, Park WS.
    Vascul Pharmacol; 2013 Sep 15; 59(3-4):90-5. PubMed ID: 23876554
    [Abstract] [Full Text] [Related]

  • 13. Beneficial effect of T-type calcium channel blockers on endothelial function in patients with essential hypertension.
    Oshima T, Ozono R, Yano Y, Higashi Y, Teragawa H, Miho N, Ishida T, Ishida M, Yoshizumi M, Kambe M.
    Hypertens Res; 2005 Nov 15; 28(11):889-94. PubMed ID: 16555577
    [Abstract] [Full Text] [Related]

  • 14. Effect of efonidipine and ACE inhibitors on proteinuria in human hypertension with renal impairment.
    Hayashi K, Kumagai H, Saruta T.
    Am J Hypertens; 2003 Feb 15; 16(2):116-22. PubMed ID: 12559677
    [Abstract] [Full Text] [Related]

  • 15. Comparison of the effects of efonidipine and amlodipine on aldosterone in patients with hypertension.
    Tanaka T, Tsutamoto T, Sakai H, Fujii M, Yamamoto T, Horie M.
    Hypertens Res; 2007 Aug 15; 30(8):691-7. PubMed ID: 17917316
    [Abstract] [Full Text] [Related]

  • 16. Effects of the antihypertensive drug efonidipine hydrochloride on albuminuria and renal histopathology in young spontaneously hypertensive rats with diabetes.
    Takeda M, Shou I, Tomino Y.
    Gen Pharmacol; 1998 May 15; 30(5):749-52. PubMed ID: 9559329
    [Abstract] [Full Text] [Related]

  • 17. Long-term effect of efonidipine therapy on plasma aldosterone and left ventricular mass index in patients with essential hypertension.
    Tsutamoto T, Tanaka T, Nishiyama K, Yamaji M, Kawahara C, Fujii M, Yamamoto T, Horie M.
    Hypertens Res; 2009 Aug 15; 32(8):670-4. PubMed ID: 19498438
    [Abstract] [Full Text] [Related]

  • 18. Post-ischemic administration of nimodipine following focal cerebral ischemic-reperfusion injury in rats alleviated excitotoxicity, neurobehavioural alterations and partially the bioenergetics.
    Babu CS, Ramanathan M.
    Int J Dev Neurosci; 2011 Feb 15; 29(1):93-105. PubMed ID: 20713150
    [Abstract] [Full Text] [Related]

  • 19. T-type calcium channel blockade as a therapeutic strategy against renal injury in rats with subtotal nephrectomy.
    Sugano N, Wakino S, Kanda T, Tatematsu S, Homma K, Yoshioka K, Hasegawa K, Hara Y, Suetsugu Y, Yoshizawa T, Hara Y, Utsunomiya Y, Tokudome G, Hosoya T, Saruta T, Hayashi K.
    Kidney Int; 2008 Apr 15; 73(7):826-34. PubMed ID: 18200001
    [Abstract] [Full Text] [Related]

  • 20. Combination of Ligusticum chuanxiong and Radix Paeoniae ameliorate focal cerebral ischemic in MCAO rats via endoplasmic reticulum stress-dependent apoptotic signaling pathway.
    Gu J, Chen J, Yang N, Hou X, Wang J, Tan X, Feng L, Jia X.
    J Ethnopharmacol; 2016 Jul 01; 187():313-24. PubMed ID: 27108052
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.